Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass
- PMID: 33813683
- PMCID: PMC8175244
- DOI: 10.1007/s11695-021-05390-1
Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is a common condition in patients with obesity. Bariatric surgery has often been proposed as a viable treatment option, but the ideal surgical procedure remains unclear. Inconsistently, reports on postoperative deterioration of liver function put further doubt on which technique to apply. Aim of this study was to assess the impact of Roux-en-Y-gastric bypass (RYGB) and sleeve gastrectomy (SG) on the postoperative recovery of liver function.
Methods: A total of 175 patients with obesity that underwent bariatric surgery in our institution were included in this prospective cohort study. BMI, laboratory values, and liver function capacity (using LiMAx) were assessed preoperatively and at 6 and 12 months postoperatively. Generalized linear model (GLM) was performed to determine variables influencing liver function capacity after the operation.
Results: Prior to operations, 64% of patients presented with a diminished liver function capacity, as measured by LiMAx test. Liver function capacity significantly recovered after 12 months in the SG group (300 μg/kg/h preop vs. 367 μg/kg/h postop) but not in the RYGB group (306 μg/kg/h preop vs. 349 μg/kg/h). Preoperative factors impeding liver function recovery included type 2 diabetes mellitus (T2DM), weight, male sex, AST/thrombocyte ratio (APRI), and gamma-glutamyltransferase (GGT).
Conclusion: Bariatric surgery, especially sleeve gastrectomy, leads to an improvement of liver function. However, in some patients with T2DM, higher preoperative weight and male sex postoperative deterioration of liver function capacity may occur.
Keywords: Bariatric surgery; LiMAx; Liver function; NAFLD; Roux-en-Y-gastric bypass; Sleeve gastrectomy.
Conflict of interest statement
The authors declare no competing interests.
Figures


References
-
- Younossi ZM. Non-alcoholic fatty liver disease—a global public health perspective. J Hepatol. 2019;70(3):531–544. - PubMed
-
- Otgonsuren M, Stepanova M, Gerber L, Younossi ZM. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58(4):1132–1140. - PubMed
-
- Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. - PubMed
-
- Souto KP, Meinhardt NG, Ramos MJ, Ulbrich-Kulkzynski JM, Stein AT, Damin DC. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Surg Obes Relat Dis. 2018;14(1):66–73. - PubMed
-
- Waits SA, Sheetz KH, Ghaferi AA. Considering bariatric surgery in patients with nonalcoholic steatohepatitis-worth the risk. JAMA Netw Open. 2019;2(2):e190053. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous